H o m e H o m e

A b o u t A b o u t

N e w s N e w s

C a r e e r s C a r e e r s

Contact
Paramétrage des cookies

These cookies are necessary for the proper functioning of the site. They cannot be deactivated.

These cookies enable us to measure the number of visits, visitors and sources of traffic to our site (content of paths, etc.), and to compile statistics in order to improve its quality, ergonomics and performance.

Marketing cookies are used to track visitors through websites. The aim is to display ads that are relevant and interesting to the individual user and therefore more valuable to third-party publishers and advertisers.

This site uses cookies to improve our services. By clicking on “accept”, you agree to the use of all cookies.
Go back

Spotlight Medical Announces Publication in Journal of Clinical Oncology Validating AI Pathology Assay That Identifies Low-Risk Subgroup Within Clinically High-Risk Early ER+/HER2- Breast Cancer

25 Aug 2025
Press release

The assay identifies a biologically low-risk subgroup within clinically high-risk patients, with outcomes similar to stage I disease, potentially sparing 50,000 women each year from unnecessary treatment intensification.

Read more

Read more news

25 Aug 2025

Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay

12 Jul 2024

Spotlight Medical Secures €6.2M in Seed Funding to Enhance Cancer Treatment Strategies with AI-Powered Prognosis Tests

27 Jun 2024

Launch of Spotlight Medical, a spin-off from Institut Curie, dedicated to transforming the way we treat cancer

No results

© Spotlight Medical 2025